Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.
Open Access
- 1 March 1993
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 91 (3), 1028-1034
- https://doi.org/10.1172/jci116259
Abstract
The hypertriglyceridemia of infection was traditionally thought to represent the mobilization of substrate to fuel the body's response to the infectious challenge. However, we have previously shown that triglyceride-rich lipoproteins can protect against endotoxin-induced lethality. The current studies examine the mechanism by which this protection occurs. Rats infused with a lethal dose of endotoxin preincubated with chylomicrons had a reduced mortality compared with rats infused with endotoxin alone (15 vs. 76%, P < 0.001). Preincubation with chylomicrons increased the rate of clearance of endotoxin from plasma and doubled the amount of endotoxin cleared by the liver (30 +/- 1 vs. 14 +/- 2% of the total infused radiolabel, P < 0.001). In addition, autoradiographic studies showed that chylomicrons directed more of the endotoxin to hepatocytes and away from hepatic macrophages. Rats infused with endotoxin plus chylomicrons also showed reduced peak serum levels of tumor necrosis factor as compared with controls (14.2 +/- 3.3 vs. 44.9 +/- 9.5 ng/ml, mean +/- SEM, P = 0.014). In separate experiments, chylomicrons (1,000 mg triglyceride/kg) or saline were infused 10 min before the infusion of endotoxin. Chylomicron pretreatment resulted in a reduced mortality compared with rats infused with endotoxin alone (22 vs. 78%, P < 0.005). Therefore, chylomicrons can protect against endotoxin-induced lethality with and without preincubation with endotoxin. The mechanism by which chylomicrons protect against endotoxin appears to involve the shunting of endotoxin to hepatocytes and away from macrophages, thereby decreasing macrophage activation and the secretion of cytokines.Keywords
This publication has 51 references indexed in Scilit:
- Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytesFEBS Letters, 1989
- Cultured Kupffer cells, isolated from human and rat liver biopsies, ingest endotoxinJournal of Hepatology, 1988
- Neutralization of Mouse Xenotropic Virus by Lipoproteins Involves Binding to the VirionsJournal of General Virology, 1988
- Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form.JCI Insight, 1988
- Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro.The Journal of cell biology, 1986
- Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.JCI Insight, 1984
- Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey.JCI Insight, 1981
- Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.JCI Insight, 1981
- Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removalMolecular and Biochemical Parasitology, 1980
- The preparation and characterization of a radioiodinated bacterial lipopolysaccharideImmunochemistry, 1978